Viewing Study NCT00256269


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-29 @ 9:08 AM
Study NCT ID: NCT00256269
Status: TERMINATED
Last Update Posted: 2018-01-26
First Post: 2005-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
Sponsor: University of California, Irvine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UCI 04-09
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View